Results 51 to 60 of about 35,320 (249)

PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE

Фармакоэкономика, 2015
pharmacoepidemiology is a well recognized throughout the world scientific discipline studying the use of and the effects of drugs in the whole population or in large groups of people in order to improve efficacy and safety of pharmacotherapy. Despite its
S. A. Rachina, R. S. Kozlov, Yu. A. Belkova   +2 more
doaj  

“My Addiction Doesn’t Define Me”—Experiences of Stigma among Mothers with Opioid Use Disorder

Pharmacoepidemiology
Opioid use in women has increased by 300% since 1999, and opioid use disorder among pregnant women has quadrupled. The stigma of substance use disorder is a significant barrier to treatment, especially among women.
Christine Bakos-Block, Andrea Yatsco, A. Sarah Cohen, Francine Vega, Tiffany Champagne-Langabeer   +4 more
doaj   +1 more source

A Retrospective Review of COVID-19 Medicines Information Queries in a Quaternary Hospital with Unique COVID-19 Border Controls

Pharmacoepidemiology, 2023
Background: Medicines information (MI) is a specialist area of pharmacy that provides evidence-based answers to often complex medication queries, utilising resources such as textbooks and databases.
Jeanie Misko, Matthew D. M. Rawlins
doaj   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY

Фармакоэкономика, 2015
: pharmacoepidemiology has recently evolved into a self-dependent post-marketing disciplinefrom clinical pharmacology, borrowing its methodology and analyticaltools from epidemiology.
T. L. Galankin, A. S. Kolbin
doaj  

Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19

Pharmacoepidemiology
Severe acute respiratory syndrome coronavirus 2 has infected millions of people, but about 20% of infected individuals do not develop symptoms. COVID-19 is an inflammatory disease that affects a portion of individuals infected with the virus and it is ...
Alireza FakhriRavari, Mazyar Malakouti
doaj   +1 more source

The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies. [PDF]

, 2015
PURPOSE: The aims of this study were two-fold: (i) to investigate the effect of exposure to antibiotic agents on the risk of acute liver injury using a self-controlled case series and case-crossover study and (ii) to compare the results between the case ...
Brauer, Ruth, Douglas, Ian, Feudjo Tepie, Maurille, Klungel, Olaf, Pharmacoepidemiology and Clinical Pharmacology, Reynolds, Robert, Ruigómez, Ana, Smeeth, Liam, Sub Pharmacotherapy, Theoretical   +8 more
core   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Maternal Medication Use in Pregnancy: A Narrative Review on Assessing and Communicating the “Risk” of Birth Defects to the Patient

Pharmacoepidemiology
The state of knowledge regarding the teratogenic effects of maternal use of medications during pregnancy is constantly evolving and is often uncertain. Timely access to high-quality information may reduce prolonged harmful exposures, decrease the number ...
Sura Alwan, Kimberly S. Grant
doaj   +1 more source